These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11363519)

  • 1. Europeans outraged over expanded access.
    Alcorn K; Nary G; Pernet AG; Surchio JL; Weiner JD
    J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):48-51. PubMed ID: 11363519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whatever happened to expanded access?
    Notes Undergr; 1997; (No 35):2-3. PubMed ID: 11364564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS task force grapples with faster access to protease drugs.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):6-11. PubMed ID: 11362314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitor approvals: will people be cut off drug? Followup studies proposal needs support.
    James JS
    AIDS Treat News; 1996 Mar; (no 242):3. PubMed ID: 11363191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New drugs, new obstacles in the fight against HIV].
    Fonseca MS
    Sidahora; 1996; ():13-4. PubMed ID: 11364289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded access for experimental AIDS drugs.
    Barr D; Gilden D
    GMHC Treat Issues; 1995 Sep; 9(9):2. PubMed ID: 11362908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Europe learns from US drug mistakes.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):39. PubMed ID: 11363346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitor expanded access.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):3. PubMed ID: 11362689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA evaluates accelerated approval process. Food and Drug Administration.
    Common Factor; 1995 Apr; (no 10):18. PubMed ID: 11362343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
    Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS activists seek speedy access to protease drugs...
    Gavaghan H
    Nature; 1995 Mar; 374(6517):4. PubMed ID: 7870168
    [No Abstract]   [Full Text] [Related]  

  • 12. Abbott AIDS medicine gets FDA approval earlier than expected.
    AIDS Read; 2000 Oct; 10(10):574. PubMed ID: 11068792
    [No Abstract]   [Full Text] [Related]  

  • 13. It's the bureaucracy, stupid.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Sep; 2(9):57. PubMed ID: 11363892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir (Crixivan), Merck protease inhibitor, approved.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: time to end the death trials.
    James JS
    AIDS Treat News; 1996 Aug; (no 252):1-4. PubMed ID: 11363751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abbott: major protest over lack of access.
    AIDS Treat News; 1995 May; (no 223):7. PubMed ID: 11362468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritonavir, Abbott protease inhibitor, approved.
    AIDS Treat News; 1996 Mar; (no 243):2-3. PubMed ID: 11363300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2000 PWAs to get ritonavir via expanded access.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Europe out of step with the US.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):33-4. PubMed ID: 11363328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.